Piro Lito
Impact in
- Oncology top 2%
- Molecular Biology top 5%
- Melanoma and MAPK Pathways
- Protein Kinase Regulation and GTPase Signaling
- PI3K/AKT/mTOR signaling in cancer
- Cancer therapeutics and mechanisms
Papers in
-
- Melanoma and MAPK Pathways 8
- Protein Kinase Regulation and GTPase Signaling 6
- Fibroblast Growth Factor Research 3
- PI3K/AKT/mTOR signaling in cancer 3
- Oncology 14
- Colorectal Cancer Treatments and Studies 4
- Cancer-related Molecular Pathways 3
- Co-authors
- Neal Rosen (7 shared papers)David B. Solit (2 shared papers)Martha Solomon (3 shared papers)Lian‐Sheng Li (1 shared paper)Jenny Y. Xue (7 shared papers)Rasmus Hansen (1 shared paper)Dong-Sung Kim (4 shared papers)Elisa de Stanchina (4 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Clinical Cancer Research (4 papers)Cancer Cell (3 papers)Science (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
Piro Lito
29 papers receiving 2.8k citations
Piro Lito's Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 1.1k
- Molecular Biology 1.9k
- Cancer Research 302
- Pathology and Forensic Medicine 311
- Pulmonary and Respiratory Medicine 538
Countries citing papers authored by Piro Lito
This map shows the geographic impact of Piro Lito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piro Lito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piro Lito more than expected).
Fields of papers citing papers by Piro Lito
This network shows the impact of papers produced by Piro Lito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piro Lito. The network helps show where Piro Lito may publish in the future.
Co-authors
The 25 scholars most cited alongside Piro Lito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism Hit paper breakdown → | 2016 | 471 |
| 2 | Tumor adaptation and resistance to RAF inhibitors Hit paper breakdown → | 2013 | 421 |
| 3 | Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas Hit paper breakdown → | 2012 | 415 |
| 4 | Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition Hit paper breakdown → | 2020 | 336 |
| 5 | 2017 | 322 | |
| 6 | 2014 | 230 | |
| 7 | 2020 | 155 | |
| 8 | 2016 | 108 | |
| 9 | 2021 | 84 | |
| 10 | 2021 | 56 | |
| 11 | 2019 | 37 | |
| 12 | 2007 | 29 | |
| 13 | 2023 | 24 | |
| 14 | 2008 | 19 | |
| 15 | 2024 | 19 | |
| 16 | 2009 | 11 | |
| 17 | 2019 | 11 | |
| 18 | 2021 | 10 | |
| 19 | 2021 | 9 | |
| 20 | 2022 | 5 |
About Piro Lito
Piro Lito is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cell Biology and Cancer Research, having authored 30 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Melanoma and MAPK Pathways (8 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer-related Molecular Pathways (3 papers), Fibroblast Growth Factor Research (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (1.1k citations), Molecular Biology (1.9k citations), Cancer Research (302 citations), Pathology and Forensic Medicine (311 citations) and Pulmonary and Respiratory Medicine (538 citations). Piro Lito has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Neal Rosen, David B. Solit, Martha Solomon, Lian‐Sheng Li, Jenny Y. Xue, Rasmus Hansen, Dong-Sung Kim, Elisa de Stanchina, Eric W. Joseph and Alberto Vides. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer Cell, Science and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.